Journals / Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi / 2020 / Cilt: 7 - Sayı: 1

How is Aurora Kinase AExpression Altered in Chronic Lymphocytic Leukemia?

Pages
24–29
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Positive immunohistochemical staining for Aurora kinase A was significantly more frequent in CLL patients (p 0.05 for all).Aurora kinase A may play a role in the pathogenesis of CLL but this role may not be as evident as it has previously been specified.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aurora kinase A is an enzyme which regulates the maturation and separation of centrosomes and the assembly and stability of mitotic spindles during mitosis.
📊
Key Findings & Data:The dysregulation of Aurora kinase A is related with aneuploidy and a pronounced increase in cancerrisk.
💡
Conclusion & Impact:Positive immunohistochemical staining for Aurora kinase A was significantly more frequent in CLL patients (p 0.05 for all).Aurora kinase A may play a role in the pathogenesis of CLL but this role may not be as evident as it has previously been specified.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Aurora kinase A is an enzyme which regulates the maturation and separation of centrosomes and the assembly and stability of mitotic spindles during mitosis. The dysregulation of Aurora kinase A is related with aneuploidy and a pronounced increase in cancerrisk. This study aims to determine how the expression of Aurora kinase A is altered in chronic lymphocytic leukemia (CLL). This prospective case-control study reviewed 41 patients who were newly diagnosed with CLL and 18 patients with benign hematologicaldiseases. Bone marrow aspiration and biopsy were performed in all patients. Aurora kinase A expression in bone marrow cells was assessed by quantitative reverse transcriptase-polymerase chain reaction. Bone marrow specimens were immunohistochemically stained for Aurora-A antibody. Chromosomal abnormalities including 13q deletion, 17p deletion and trisomy 12 were investigated by fluorescence in situ hybridization in bone marrow aspirates of CLL patients. The CLL patients and the patients with benign hematological diseases were statistically similar in aspect of Aurora kinase A mRNA expression through β-actin and GAPDH housekeeping genes (respectively p=0.742 and p=0.229). Positive immunohistochemical staining for Aurora kinase A was significantly more frequent in CLL patients (p 0.05 for all).Aurora kinase A may play a role in the pathogenesis of CLL but this role may not be as evident as it has previously been specified.

🔖

Cite This Article

ÇETİN, D., PEKTAŞ, G., BOZKURT, G., DÖGER, F. K., YAVAŞOĞLU, İ., BOLAMAN, Z., KADIKÖYLÜ, G. (2020). How is Aurora Kinase AExpression Altered in Chronic Lymphocytic Leukemia?. Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi, Cilt: 7 - Sayı: 1, 24–29. https://ajindex.com/articles/294060

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Choi MY, Kashyap MK, Kumar D. The chronic lymphocytic leukemia microenvironment: Beyond the B-cell receptor.Best Pract Res Clin Haematol. 2016
  2. 29(1):40–53. 2.Galletti G, Caligaris-Cappio F, Bertilaccio MT. B cells and macrophages pursue a common path toward the development and progression of chronic lymphocytic leukemia. Leukemia. 2016
  3. 30(12):2293–301. 3.Alsagaby SA, Brennan P, Pepper C. Key molecular drivers ofchronic lymphocytic leukemia. Clin Lymphoma MyelomaLeuk. 2016
  4. 16(11):593–606. 4.Wang G, Jiang Q, Zhang C. The role of mitotic kinases in coupling the centrosome cycle with the assembly of the mitotic spindle. J Cell Sci. 2014
  5. 127(Pt 19):4111–22. 5.Gavriilidis P, Giakoustidis A, Giakoustidis D. Aurora kinasesand potential medical applications of Aurora kinase inhibitors: A review. J Clin Med Res. 2015
  6. 7(10):742–51. 6.Afonso O, Figueiredo AC, Maiato H. Late mitotic functions of Aurora kinases. Chromosoma. 2017
  7. 126(1):93–103. 7.Sen S, Katayama H, Sasai K. Functional significance of Aurora kinase A in centrosome amplification and genomic instability. Adv Exp Med Biol. 2008
  8. 99–108. 8.Nikonova AS, Astsaturov I, Serebriiskii IG, Dunbrack RL Jr,Golemis EA. Aurora A kinase (AURKA) in normal and pathological cell division. Cell Mol Life Sci. 2013
  9. 70(4):661–87. 9.Wang Y, Sun H, Wang Z, et al. Aurora-A: a potential DNA repair modulator. Tumour Biol. 2014
  10. 35(4):2831–6. 10. D'Assoro AB, Haddad T, Galanis E. Aurora-A Kinase as a promising therapeutic target in cancer. Front Oncol. 2016
  11. Treekitkarnmongkol W, Katayama H, Kai K, et al. Aurorakinase-A overexpression in mouse mammary epithelium induces mammary adenocarcinomas harboring genetic alterations shared with human breast cancer. Carcinogenesis. 2016
  12. 37(12):1180–9. 12. Zhang J, Li B, Yang Q, Zhang P, Wang H. Prognostic value of Aurora kinase A (AURKA) expression among solid tumor patients: a systematic review and meta-analysis. Jpn J Clin Oncol. 2015
  13. 45(7):629–36. 13. Casey NP, Fujiwara H, Ochi T, Yasukawa M. Novelimmunotherapy for adult T-cell leukemia/lymphoma: Targeting aurora kinase A. Oncoimmunology. 2016
  14. 5(11): e1239006. 14. Wang LX, Wang JD, Chen JJ, et al. Aurora A kinase inhibitor AKI603 induces cellular senescence in chronic myeloidleukemia cells harboring T315I mutation. Sci Rep. 2016
  15. 35533. 15. Kelly KR, Shea TC, Goy A, et al. Phase I study of MLN8237--investigational Aurora A kinase inhibitor--in relapsed/refractory multiple myeloma, non-Hodgkin lymphoma and chroni